Merck & Co., Inc. (MRK) Income statement

Top 20 of 29 line items reported by MRK · 250+ in the full API →

Merck & Co., Inc. (MRK) · Income Statement

Consolidated Statements of Operations

Quarterly · In millions USD, except per-share data · Latest filed Nov 4, 2026 · FY ends Dec 31

Three Months Ended
Q3 2026
Sep 30, 2026
Q2 2026
Jun 30, 2026
Q1 2026
Mar 31, 2026
Q4 2025
Dec 31, 2025
Q3 2025
Sep 30, 2025
Trend
Total Revenue$18,085$16,607$16,286$16,400$17,276
Cost of Revenue4,8924,3954,1955,5513,855
Gross Profit$13,193$12,212$12,091$10,849$13,421
Other Operating Expenses7,42312,64515,2926,7846,867
Total Operating Expenses12,31517,04019,48712,33510,722
Operating Income$5,770$(433)$(3,201)$4,065$6,554
EBIT (Earnings Before Interest & Tax)5,770(433)(3,201)4,0656,554
Add: Depreciation & Amortization7255985811,493532
EBITDA (Non-GAAP)$6,495$165$(2,620)$5,558$7,086
Interest Income5235356996
Interest Expense-546-525-479-411-327
Investment Gains (Losses)401242168(195)373
Foreign Exchange Gain (Loss)(63)(37)(38)(99)(56)
Non-Operating Income (Expense)$(156)$(285)$(314)$(636)$86
Income Before Taxes (EBT)$5,559$(683)$(3,534)$3,420$6,745
Provision for Income Taxes492654709458958
Effective Tax Rate8.9%(95.8%)(20.1%)13.4%14.2%
Net Income$5,065$(1,335)$(4,240)$2,963$5,785
Diluted Earnings Per Share$2.04($0.54)($1.72)$1.19$2.32
Gross Margin72.9%73.5%74.2%66.2%77.7%
9 more line items available via the API
Research & DevelopmentSales, General & AdministrativeGain (Loss) on Equity SecuritiesShares OutstandingDiluted Shares OutstandingBasic Earnings Per ShareOperating MarginOther OpEx MarginNet Margin
Ask your agent:get_financialsAPIGET /api/v1/companies/MRK/income-statement?period=quarterly&years=2Docs →